ALFA FinderBSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.
Thyrocare Technologies Ltd: key numbers
- Share price
- ₹493.10
- Market cap
- ₹7,848 Cr
- Revenue (annual)
- ₹829.0 Cr
- Net profit (annual)
- ₹163.0 Cr
- P/E (TTM)
- 54.4×Sector 53.9×
- Promoter holding
- 51.02%-9.90% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thyrocare Technologies Ltd
All →Thyrocare Technologies Other Announcement
Designated person Rahul Guha bought 2,121 Thyrocare shares via market purchase on November 6, 2026, worth ₹0.10 Crore. Post-trade holding is 200,859 shares.
- Value
- ₹0.10 Cr
Thyrocare Technologies Employee Stock Options
Thyrocare allotted 1,94,289 equity shares under its Employee Stock Option Scheme. The allotment lifts paid-up capital to Rs 159.36 crore.
Thyrocare Technologies Management Change
Thyrocare Technologies' Chief Scientific Officer, Dr. Preet Kaur, resigns effective November 6, 2026. The company is identifying a replacement and will disclose details later.
Thyrocare Technologies Other Announcement
Thyrocare disclosed NSE market purchases by an immediate relative and a KMP on 2 November 2026. Combined consideration is about Rs 0.11 Crore, with no promoter involved.
- Value
- ₹0.11 Cr
Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
- Value
- ₹141.4 Cr
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Other promoter selling announcements
All →JK Cement Promoter Selling: ₹0.53 Cr
Promoter group member Kalpana Singhania sold 1,000 JK Cement shares on the NSE on 05-11-2026. Holding fell to 324,296 shares, roughly 0.41%, worth about Rs.0.53 Crore.
- Value
- ₹0.53 Cr
Alivus Life Sciences Promoter Selling
Nirma Limited, a promoter of Alivus Life Sciences, sold 36,80,000 shares (2.99%) in the open market on 6 November 2026. Promoter holding falls from 74.73% to 71.74%.
KPIT Technologies Promoter Selling: ₹0.41 Cr
KPIT Technologies promoter Hemlata Shende sold 8,000 equity shares in an open-market sale on November 4, 2026, reducing her holding to nil. The transaction value is about Rs.0.41 Crore.
- Value
- ₹0.41 Cr
JK Cement Promoter Selling
Promoter Kalpana Singhania sold 1,000 JK Cement shares via open market on 05 November 2026. Holding fell to 324,296 shares, with the stake effectively unchanged at 0.41%.
Jhaveri Credits & Capital Promoter Selling: ₹0 Cr
Promoter group member Bhumit Patel sold 90 shares via BSE market sale for Rs.15,600. Holding fell to 42,076 shares, 0.37 percent.
- Value
- ₹0.00 Cr
Sri Lotus Developers and Realty Promoter Selling: ₹573 Cr
Promoter Anand Kamalnayan Pandit sold 2.39 crore shares via NSE market sale, worth Rs.572.96 Crore. Promoter holding falls from 70.03% to 65.14%.
- Value
- ₹573.0 Cr